Selumetinib (AZD6244)
Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0566 |
| Pricing | 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, 5.0 g, 10.0 g, 20.0 g, inquire |